The BEAUTIFUL study: randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction – baseline. failure.9 A trial of ivabradine involving patients well as for the fidelity of this report to the trial tricular systolic dysfunction (BEAUTIFUL). The BEAUTIFUL Study: Effects of Ivabradine in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction.
|Published (Last):||19 December 2009|
|PDF File Size:||20.24 Mb|
|ePub File Size:||12.38 Mb|
|Price:||Free* [*Free Regsitration Required]|
Recommend FPrime to your librarian or information manager to request an extended free trial for all users at your institution. User comments must be in English, comprehensible and relevant to the article under discussion. F reserves the right to remove any comments that it considers in its absolute discretion to be inappropriate, offensive or otherwise in breach of the Terms and Brautiful relating to Materials including Comments.
Please disclose any competing interests that might be ivabraidne to influence your judgment of the validity or importance of the article, or any recommendation or review. Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality.
Consider the following examples, but note that this is not an exhaustive list:. The use of certain tools provided by this website is subject to additional Terms and Conditions. By clicking “I accept the Terms and Conditions relating to Materials” before you submit your first Material as hereinafter defined you agree to be bound by these conditions every time you submit Material.
With the BEAUTIFUL Results, Procoralan* (ivabradine) is the First Antianginal Tr
A summary of the content will be automatically included. F does not store recipient email addresses. Classified as close Confirmation 1. Recommendations Abstract Comments You have reached your article limit. Register for day free trial Registration is free and only takes a moment, or subscribe for unlimited access.
Register Already registered with FPrime? Institutional access Recommend FPrime to your librarian or information manager to request an extended free trial for all users at your institution.
Recommend to your librarian.
There was a problem providing the content you requested
FPrime is an expert-curated resource to help you find the articles of greatest interest and relevance to you. Ivabradine specifically inhibits the I f current in the sinoatrial node to lower heart rate, without tiral other aspects of cardiac function. We aimed to test whether lowering the heart rate with ivabradine reduces cardiovascular death beautitul morbidity in patients with coronary artery disease and left-ventricular systolic dysfunction.
Between December,and December,we screened 12 patients at centres in 33 countries. The primary endpoint was a composite of cardiovascular death, admission to hospital for acute myocardial infarction, and admission to hospital for new onset or worsening heart failure.
We analysed patients by intention to treat. The study is registered with ClinicalTrials.
Mean heart rate at baseline was Median follow-up was 19 months IQR Ivabradine reduced heart rate by 6 bpm SE 0. Ivabradine did not affect the primary composite endpoint hazard ratio 1.
In a prespecified subgroup of patients with heart rate of 70 bpm or greater, ivabradine treatment did not affect the primary composite outcome hazard ratio 0. However, it did reduce secondary endpoints: Reduction in heart rate with ivabradine does not improve cardiac outcomes in all patients with stable coronary artery disease and left-ventricular systolic dysfunction, but could be used to reduce the incidence of coronary artery disease outcomes in a subgroup of patients who have heart rates of 70 bpm or greater.
This entry form currently does not support special characters. Disclosures Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality.
Consider the following examples, but note that this is not an exhaustive list: Examples of ‘Non-Financial Competing Interests’ Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. You have a close personal relationship e. You are a close professional associate of any of the authors e.
BEAUTIFUL TRIAL –
You work at the same institute as any of the authors. You are an Editor for the journal in which the article is published. Examples of ‘Financial Competing Interests’ You expect to receive, or in the past 4 years have received, any of the following from any commercial organization that may gain financially from your submission: You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.
I am an author of this article.
Ivvabradine am a Faculty Member who recommended this article. Neither of the above. This Agreement shall begin on the date hereof. Certain parts of this website offer the opportunity for users to post opinions, information and material including without limitation academic papers and data ‘Material’ in areas of the website. F does not claim any ownership in the Material that you or any other user posts. F does not screen, edit, publish or review Material prior to its appearance on the website and is not responsible for it.
Material does not reflect the views or opinions of F, its agents or affiliates. Any view or opinion expressed in any Material is the view or opinion of the person who posts such view or opinion. Accordingly you may only post Material that you have the right to do so. You may not use the website for any unlawful purpose, including without limitation, to upload, post, download or otherwise use any Material that you do not have the copyright owners permission to so upload, post, download or otherwise use, or that would result in you being in breach of these terms beauutiful conditions.
F reserves the right to monitor all Material and to remove any Material which it considers in its absolute discretion to be unlawful, inappropriate, offensive or otherwise in breach of these Terms and Conditions. By posting or uploading Material you warrant and represent that: You are entitled to post or upload the Material on the website and have all necessary licenses and consents to do so; the Material does not infringe any intellectual property right, including without limitation copyright, uvabradine or trademark, or other proprietary right of any third party; the Material does not trrial any defamatory, libellous, offensive, indecent or otherwise unlawful material or material which is an invasion of privacy; the Material does not contain any contaminating or destructive features or devices such as viruses, time bombs or coding designed to interrupt, destroy or limit the functionality of this website or any of this website’s user’s computer equipment or software; the Material will not be used to solicit or promote business or custom or present commercial activities or unlawful activity; and the Material is in compliance with all applicable laws.
By posting Material you grant to F an irrevocable non-exclusive royalty-free license to keep a copy of Material for a reasonable period and as necessary troal enable it to comply with its legal obligations. You hereby agree to indemnify and keep indemnified F, its affiliates, triwl and agents from and against any and all losses including without limitation direct, indirect and consequential losscosts, claims, damages or expenses of whatever nature and howsoever caused arising directly or indirectly from any breach ivbradine these Terms and Conditions or arising from the Material posted on this website or content contained in any email sent using the facilities provided by the website by you ivabadine without limitation as a beajtiful of any infringement of any intellectual property or other proprietary rights, libel, defamation, obscenity or the Material being otherwise unlawful.
These terms shall be governed by and construed in accordance with English Law. I would like to receive updates when further comments, recommendations, or dissenting opinions are publishing on this article. Don’t have an account?